药物开发研究 SCIE

期刊简介预计审稿时间： 较慢,6-12周

Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.

《药物开发研究》专注于与发现和开发新治疗实体相关的研究主题。该期刊发表有关药物化学、药理学、生物技术和生物制药、毒理学以及药物输送、配方和药代动力学的原创研究文章。该期刊欢迎有关人类治疗学所有领域的新化合物和技术的手稿，以及涉及药物发现和开发过程的全球管理、医疗保健政策和监管问题。除了全文文章外，《药物开发研究》还发表有关重要且及时的新研究成果的简要报告以及深入的评论文章。该期刊还定期出版特别专题，专门讨论特定化合物类别、新技术以及药物发现和开发的广泛方面。

《Drug Development Research》(药物开发研究)编辑部通讯方式为WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。